BEIGENE
LIVE

Serial Number

90647320

Owner

BeOne Medicines I GmbH

Attorney

Kristen S. Ruisi

First Use Date

Sep 20, 2021

Filing Date

Apr 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BEIGENE Trademark

Serial Number: 90647320 • Registration: 6860858

BEIGENE is a trademark filed by BeOne Medicines I GmbH on April 15, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BeOne Medicines I GmbH (66 trademarks)

Aeschengraben 27
Basel 4051 , CH

Entity Type: 27

BG NC 1, LTD. (15 trademarks)

94 SOLARIS AVENUE
GRAND CAYMAN 1-1108 , KY

Entity Type: 16

BeiGene, Ltd. (84 trademarks)

San Mateo, CA 94404

Entity Type: 99

BEONE MEDICINES LTD. (20 trademarks)

AESCHENGRABEN 27
BASEL 4051 , CH

Entity Type: 16

Trademark Details

Filing Date

April 15, 2021

Registration Date

September 27, 2022

First Use Anywhere

September 20, 2021

First Use in Commerce

September 20, 2021

Published for Opposition

October 19, 2021

Goods & Services

Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design

Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 29, 2025 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 29, 2025 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 10, 2025 ASGN
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 9, 2025 ASCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 8, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 8, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 8, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 8, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 8, 2022 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 23, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 22, 2022 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 19, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 18, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 11, 2022 GNFN
FINAL REFUSAL E-MAILED
Aug 11, 2022 GNFR
SU - FINAL REFUSAL - WRITTEN
Aug 11, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 11, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 7, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 7, 2022 CNRT
DATA MODIFICATION COMPLETED
Jun 1, 2022 DMCC
ASSIGNED TO LIE
Jun 1, 2022 ALIE
STATEMENT OF USE PROCESSING COMPLETE
May 26, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 26, 2022 AITU
USE AMENDMENT FILED
May 12, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
May 12, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 14, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 19, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 19, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 8, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 23, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2021 NWOS
NEW APPLICATION ENTERED
Apr 19, 2021 NWAP